Applied Price Cash Flow Ratio vs Cash Per Share Analysis
APLT Stock | USD 1.14 0.10 8.06% |
Applied Therapeutics financial indicator trend analysis is way more than just evaluating Applied Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Applied Therapeutics is a good investment. Please check the relationship between Applied Therapeutics Price Cash Flow Ratio and its Cash Per Share accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.
Price Cash Flow Ratio vs Cash Per Share
Price Cash Flow Ratio vs Cash Per Share Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Applied Therapeutics Price Cash Flow Ratio account and Cash Per Share. At this time, the significance of the direction appears to have strong relationship.
The correlation between Applied Therapeutics' Price Cash Flow Ratio and Cash Per Share is 0.62. Overlapping area represents the amount of variation of Price Cash Flow Ratio that can explain the historical movement of Cash Per Share in the same time period over historical financial statements of Applied Therapeutics, assuming nothing else is changed. The correlation between historical values of Applied Therapeutics' Price Cash Flow Ratio and Cash Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price Cash Flow Ratio of Applied Therapeutics are associated (or correlated) with its Cash Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash Per Share has no effect on the direction of Price Cash Flow Ratio i.e., Applied Therapeutics' Price Cash Flow Ratio and Cash Per Share go up and down completely randomly.
Correlation Coefficient | 0.62 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Price Cash Flow Ratio
Cash Per Share
Most indicators from Applied Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Applied Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.At this time, Applied Therapeutics' Selling General Administrative is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 69.8 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 1.65 in 2024.
Applied Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Applied Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Applied Therapeutics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 48.4M | 104.5M | 89.9M | 38.4M | 54.8M | 56.5M | |
Other Current Liab | 264K | 19.8M | 16.1M | 27.9M | 67.9M | 71.3M | |
Total Current Liabilities | 14.1M | 21.2M | 26.5M | 33.4M | 71.2M | 74.7M | |
Total Stockholder Equity | 32.6M | 81.9M | 62.5M | 4.1M | (17.1M) | (16.3M) | |
Net Tangible Assets | (19.6M) | 32.6M | 81.9M | 62.5M | 71.9M | 75.5M | |
Net Debt | (16.8M) | (55.7M) | (52.6M) | (15.8M) | (49.1M) | (46.7M) | |
Retained Earnings | (66.8M) | (160.7M) | (266.3M) | (348.8M) | (468.6M) | (445.2M) | |
Accounts Payable | 8.8M | 640K | 9.5M | 4.5M | 1.7M | 1.7M | |
Cash | 18.9M | 57.5M | 53.9M | 16.7M | 49.9M | 34.4M | |
Non Current Assets Total | 2.2M | 1.9M | 1.5M | 1.1M | 447K | 424.7K | |
Other Assets | 199K | 1.9M | 200K | 1.0 | 1.15 | 1.09 | |
Cash And Short Term Investments | 38.9M | 96.8M | 80.8M | 30.6M | 49.9M | 50.1M | |
Common Stock Shares Outstanding | 12.8M | 22.0M | 25.6M | 37.8M | 84.2M | 88.5M | |
Liabilities And Stockholders Equity | 48.4M | 104.5M | 89.9M | 38.4M | 54.8M | 56.5M | |
Non Current Liabilities Total | 1.7M | 1.3M | 891K | 878K | 797K | 1.4M | |
Other Current Assets | 7.3M | 5.3M | 7.0M | 6.5M | 4.2M | 5.0M | |
Other Stockholder Equity | 51.0M | 242.8M | 329.0M | 352.8M | 451.4M | 230.2M | |
Total Liab | 15.8M | 22.6M | 27.4M | 34.3M | 72.0M | 75.6M | |
Net Invested Capital | 32.6M | 83.0M | 63.3M | 5.1M | (16.8M) | (16.0M) | |
Total Current Assets | 46.2M | 102.6M | 88.4M | 37.3M | 54.4M | 55.4M | |
Accumulated Other Comprehensive Income | (2K) | (112K) | (107K) | 51K | 45.9K | 48.2K | |
Net Working Capital | 32.1M | 81.4M | 61.9M | 3.9M | (16.8M) | (16.0M) | |
Short Term Debt | 356K | 812K | 884K | 954K | 858K | 607.2K | |
Common Stock | 1K | 2K | 3K | 5K | 8K | 8.4K | |
Capital Stock | 1K | 2K | 3K | 5K | 8K | 8.4K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.